Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,351
datasets available to search
ShareScore release 0.9.0
Dataset results
1,351 results for “Intermediates”
Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q
ClinicalTrials.gov study NCT02928419. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
Effect of Minimizing Light Exposure Intensity on Macular Function After Cataract Surgery in Patients With Early or Intermediate AMD
ClinicalTrials.gov study NCT05988827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Response-adapted Total Neoadjuvant Therapy Guided by Induction Chemotherapy in Early- and Intermediate-risk Low Rectal Cancer for Implementation of a Watch-and-wait Strategy
ClinicalTrials.gov study NCT07260526. IPD Sharing: YES. Countries: 1. Publications: 0.
Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer
ClinicalTrials.gov study NCT00657982. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Outcomes With a New Monofocal IOL Enhanced for Intermediate Vision
ClinicalTrials.gov study NCT04904887. IPD Sharing: NO. Countries: 1. Publications: 0.
Intermediate Cervical Plexus Block on Stress Response
ClinicalTrials.gov study NCT06064214. IPD Sharing: YES. Countries: 1. Publications: 0.
Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer
ClinicalTrials.gov study NCT03740191. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for
ClinicalTrials.gov study NCT00695396. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life
ClinicalTrials.gov study NCT05242562. IPD Sharing: YES. Countries: 1. Publications: 0.
Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed
ClinicalTrials.gov study NCT04462926. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke
ClinicalTrials.gov study NCT00240643. IPD Sharing: Not stated. Countries: 25. Publications: 0.
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1
ClinicalTrials.gov study NCT06744504. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
ClinicalTrials.gov study NCT05540899. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-Uvei
ClinicalTrials.gov study NCT05414201. IPD Sharing: YES. Countries: 1. Publications: 0.
Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06846489. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer
ClinicalTrials.gov study NCT01599182. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
ClinicalTrials.gov study NCT03412266. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer
ClinicalTrials.gov study NCT07230080. IPD Sharing: NO. Countries: 1. Publications: 0.
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
ClinicalTrials.gov study NCT06488222. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.